Contribution: SIF Stream 1- R&D
Immune Biosolutions Inc.
$13,442,000.00
513419
EF 2020-21 · 2020-04-29
Résumé
Immune Biosolutions inc. will develop a medical counter measure (MCM) and contribute to Canada's ability to secure an effective therapeutic in response to COVID-19.
Programme
SIF Stream 1- R&D
Bénéficiaire
Emplacement
Sherbrooke, Quebec, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
805852886
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2020-04-29 | 2020-21 | $13,442,000.00 |
| 1 | 2020-04-29 | 2020-21 | $13,442,000.00 |
| 2 | 2020-04-29 | 2020-21 | $13,442,000.00 |
Tel que publié
Additional Information
The Amendment has been completed to extend the project agreement end date from 2031-03-31 to 2031-09-30. The contribution is non-repayable.
Additional Information (French)
La modification a été effectuée pour prolonger la date de fin de l'accord de projet du 31 mars 2031 au 30 septembre 2031. La contribution n'est pas remboursable.
Agreement End Date
2023-09-30
Agreement Number
513419
Agreement Start Date
2020-04-29
Agreement Title
513419
Agreement Title (French)
513419
Agreement Type
Contribution
Agreement Value
$13,442,000.00
Amendment Date
2023-03-28
Amendment Number
2
Description
Immune Biosolutions inc. will develop a medical counter measure (MCM) and contribute to Canada's ability to secure an effective therapeutic in response to COVID-19.
Description (French)
Immune Biosolutions inc. développera une contre-mesure médicale et contribuera à la capacité du Canada à obtenir un traitement efficace en réponse à la COVID-19.
Expected Results
This project will help develop medical counter measures (MCM) and contribute to Canada's ability to secure an effective therapeutic response to COVID-19.
Expected Results (French)
Ce projet contribuera à l'élaboration de contre-mesures médicales (CMM) et à la capacité du Canada à garantir une réponse thérapeutique efficace au COVID-19.
Federal Riding
Sherbrooke
Federal Riding (French)
Sherbrooke
Federal Riding Number
24073
NAICS Code
541710
Organization Code
ic
Organization
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
Program Name
SIF Stream 1- R&D
Program Name (French)
FIS Volet 1- R&D
Program Purpose
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
Program Purpose (French)
-favoriser les activités de R-D qui accéléreront le transfert de la technologie et la commercialisation de produits, de processus et de services novateurs ;-faciliter la croissance et l'expansion des entreprises au Canada ;-attirer et conserver des investissements de grande envergure au Canada ; et-faire progresser la recherche industrielle, le développement et la démonstration de technologies grâce à la collaboration entre les universitaires, les organisations à but non lucratif et le secteur privé.
Recipient Business Number
805852886
Recipient City
Sherbrooke
Recipient Country
CA
Recipient Legal Name
Immune Biosolutions Inc.
Recipient Operating Name
Immune Biosolutions Inc.
Recipient Postal Code
J1E0M8
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
033-2020-2021-Q4-513419
